The Insights Report – Agriculture

Volpara Health Technologies (“Volpara”), which provides clinically validated software for the early detection of breast cancer, has been certified

Good news as this has the potential to create plant-based meat, dairy, baked-goods, noodles, and protein supplements.

NEXTSTELLIS was approved by the Therapeutic Goods Administration in November 2021.